We have had a major input in evaluating the effectiveness and wider impact of the pneumococcal conjugate vaccine (PCV10) in Kenya, including studies of the effect on carriage, invasive disease, burden of pneumonia and pathogen structure. We are expanding our platform of surveillance to incorporate assessments of the safety of EPI vaccines, direct and indirect effects of rotavirus vaccination, and studies of the non-specific effects of vaccination. We will examine the epidemiology of invasive salmonella infection and salmonella carriage in children and adults, and participate in the clinical development of a whole cell pneumococcal vaccine which is serotype independent.

The group is affiliated to the Kemri Wellcome Trust Research Programme and Wellcome Trust. Each dataset has a citation and DOI, facilitating attribution and connection to research publications. For information about the IBD Data Archive, please visit our website http://pcvis.org .

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

41 to 50 of 132 Results
Replication Data for: Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
Replication Data for: Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
Oct 6, 2022
Kagucia, E. Wangeci; Karia, Boniface, 2022, "Replication Data for: Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya", https://doi.org/10.7910/DVN/VTTV63, Harvard Dataverse, V2, UNF:6:apP+4G5wJSBe7DybwhuqRQ== [fileUNF]
This is a replication dataset for the publication titled: "Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya." The serosurvey was conducted at three sites, one in Kilifi County in South-Eastern Kenya, and two in Busia County in Western Kenya. The dataset contain...
Kagucia_TDA_SARS-COV2_Seroprevalence_Codebook.pdf
Kagucia_TDA_SARS-COV2_Seroprevalence_Codebook.pdf
Oct 6, 2022 - Replication Data for: Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
Adobe PDF - 105.9 KB - MD5: 1c16ba4b64438189b2fa5623b0c600dc
DocumentationVariable Codebook/Data Dictionary
Contains variable descriptions and value/coding labels
KAGUCIA_TDA_SARS-COV2_Seroprevalence_Readme_V2.txt
Oct 6, 2022 - Replication Data for: Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
Plain Text - 5.5 KB - MD5: 49bfc4447ed03ba53839c991b17a71c4
DocumentationReadme
TDA_prevalence_adjusted_for_sens_and_spec.Rmd
Oct 6, 2022 - Replication Data for: Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
Unknown - 2.0 KB - MD5: 80ab3c26e3c9ab67f25185b0d373bece
CodeR Script
Generates Test-performance-adjusted seroprevalences
TDA_SARS-COV2_Seroprevalence_data_deidentified-1.tab
Oct 6, 2022 - Replication Data for: Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
Tabular Data - 101.5 KB - 17 Variables, 830 Observations - UNF:6:m80fXbLlukGDclZPC5h4RA==
csvData
SSARS-CoV-2 test results as well as demographic and clinical information of participants.
TDA_SARS-COV2_Seroprevalence_data_deidentified.tab
Oct 6, 2022 - Replication Data for: Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
Tabular Data - 74.8 KB - 17 Variables, 830 Observations - UNF:6:AWqlLkE7HVnygEl9rSiH2g==
DataSTATA
SSARS-CoV-2 test results as well as demographic and clinical information of participants
TDA Survey 1_analysis.do
Oct 6, 2022 - Replication Data for: Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
Stata Syntax - 15.4 KB - MD5: 73a9981dcd6b927691a202b7b3b883e8
CodeSTATA
Generates descriptive statistics
Replication Data for: SARS-CoV-2 Seroprevalence in three Kenyan Health and Demographic Surveillance Sites, December 2020-May 2021
Jun 9, 2022
Otiende, Mark; Etyang, Anthony A, 2022, "Replication Data for: SARS-CoV-2 Seroprevalence in three Kenyan Health and Demographic Surveillance Sites, December 2020-May 2021", https://doi.org/10.7910/DVN/TG31BU, Harvard Dataverse, V1, UNF:6:nVkOvdQ+DSkeJCXFYxYetw== [fileUNF]
This is a replication dataset for the manuscript title: "SARS-CoV-2 Seroprevalence in three Kenyan Health and Demographic Surveillance Sites, December 2020-May 2021" submitted to PLOS Global Public Health.
kilifi_sero.tab
Jun 9, 2022 - Replication Data for: SARS-CoV-2 Seroprevalence in three Kenyan Health and Demographic Surveillance Sites, December 2020-May 2021
Tabular Data - 28.4 KB - 5 Variables, 856 Observations - UNF:6:2GCWnBEjLjcK41lXEa2S8A==
DataSTATA V15.1
ksm_sero.tab
Jun 9, 2022 - Replication Data for: SARS-CoV-2 Seroprevalence in three Kenyan Health and Demographic Surveillance Sites, December 2020-May 2021
Tabular Data - 29.9 KB - 5 Variables, 853 Observations - UNF:6:hcTjVVf18p5DkQelZE/Zgg==
DataSTATA V15.1
Add Data

Sign up or log in to create a dataverse or add a dataset.

Sign Up Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.